Salim Yazji | CMO |
James Breitmeyer | President, CEO |
Richard Vincent | CFO |
Hartaj Singh | Oppenheimer |
Carl Byrnes | Northland Capital Markets |
Rosemary Li | Cantor Fitzgerald |
Kemp Dolliver | Brookline Capital Markets |
Greetings, and welcome to the Oncternal Therapeutics First Quarter 2023 Financial Results Call. [Operator Instructions] As a reminder, this conference will be recorded.
I would now like to turn the conference over to your host, Richard Vincent, Chief Financial Officer.
Thank you, Joe. Good afternoon, everyone, and thank you for joining us today.